MetaCap

AEON Biopharma Insider Trades

NYSE: AEONHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.276-0.034 (-10.97%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $243.46K
Sales
0 · $0
Shares bought / sold
1.15M / 0
Net activity
Net buying $243,455

AEON Biopharma insider activity

Over the last 12 months, AEON Biopharma insiders reported 14 transactions on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $243,455 and sold $0 worth of stock, for net insider buying of $243,455. The most recent filing shows LYNCH TIMOTHY P (10% Owner) buying 1,150,000 shares at $0.2117 on Aug 19, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AEON's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AEON insider transactions

AEON Biopharma insider transactions
DateInsiderTypeSharesValueFiling
Aug 19, 2026LYNCH TIMOTHY P10% OwnerBuy1,150,000$243.46KForm 4
Jun 17, 2026FISCHER JOSTDirectorAward222,684—Form 4
Jun 17, 2026Thunen Shelley BDirectorAward222,684—Form 4
Jun 17, 2026Carter Eric GDirectorAward222,684—Form 4
Jun 17, 2026Forth MarcDirectorAward222,684—Form 4
Jun 17, 2026PALMISANO ROBERT JDirectorAward222,684—Form 4
Apr 2, 2026Bencich JohnCHIEF FINANCIAL OFFICERAward754,717—Form 4
Mar 4, 2026Sy JenniferPRINCIPAL ACCOUNTING OFFICERAward925,925—Form 4
Mar 4, 2026Wilson Alexander BlairCLO, CSO, and Corp SecretaryAward1,316,872—Form 4
Mar 4, 2026Oh ChadCHIEF MEDICAL OFFICERAward1,316,872—Form 4
Feb 17, 2026Bancroft Robert E.PRESIDENT & CEOAward3,000,000—Form 4
Feb 17, 2026Sy JenniferPRINCIPAL ACCOUNTING OFFICERAward575,000—Form 4
Feb 17, 2026Wilson Alexander BlairCLO, CSO, and Corp SecretaryAward862,500—Form 4
Feb 17, 2026Oh ChadCHIEF MEDICAL OFFICERAward862,500—Form 4
May 21, 2025FISCHER JOSTDirectorBuy60,000$29.25KForm 4
May 20, 2025FISCHER JOSTDirectorBuy60,000$30.36KForm 4
May 19, 2025FISCHER JOSTDirectorBuy50,000$24.94KForm 4
May 14, 2025Bancroft Robert E.President & CEOAward177,103—Form 4
Aug 31, 2024Thunen Shelley BDirectorAward36,021—Form 4
Aug 31, 2024Carter Eric GDirectorAward36,021—Form 4
Aug 31, 2024Sy JenniferPRINCIPAL ACCOUNTING OFFICERAward18,010—Form 4
Aug 31, 2024PALMISANO ROBERT JDirectorAward36,021—Form 4
Aug 31, 2024FISCHER JOSTDirectorAward36,021—Form 4
Aug 31, 2024Oh ChadCHIEF MEDICAL OFFICERAward192,117—Form 4
Aug 31, 2024Wilson Alexander BlairEXEC VP, CLO & CORP SECRETARYAward180,110—Form 4
Aug 31, 2024Forth MarcCHIEF EXECTUIVE OFFICERAward470,692—Form 4
Aug 31, 2024PALMISANO ROBERT JDirectorAward36,021—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related